Monday, November 28, 2011

Skin Cancer War Gets New Weapon

Skin cancer is not only the most common cancer; it outnumbers all other cancers ‘combined’ notes Dr. Tim Rosio. A new drug is shown to shrink skin cancer. This drug is very effective on patients with basal cell carcinoma (BCC). “Roche’s vismodegib shrank tumors or healed lesions in 43% of clinical trial participants with locally advanced basal cell carcinoma and 30% of those with another advanced form of BCC,” reported Reuters. Most of the time, skillful dermatologic excision with or without MOHS Surgery, and meticulous cosmetic dermatologic closure gives great results and cures the skin cancer.  Occasionally, however, I see in my patients and others have very advanced skin cancers, numerous cancers, or both,” says the skin cancer specialist. That’s when this medication may make a huge difference.  Skin cancer can be detected and prevented with annual skin cancer screenings. Come in today to get your yearly screening to make sure you’re free and clear of any form of skin cancer. Dr. Tim Rosio is a board certified Stanford trained Dermatologist with offices in El Dorado Hills and Auburn. To find out more information on skin cancer screenings, take a look at our youtube videos and read more articles on our blog.

No comments:

Post a Comment